1. 九游老哥J9俱乐部官网 - J9俱乐部老哥交流社区

      EN
      ×
      EN
      • 业务咨询

        中国:

        Email: marketing@jzwhm.com

        业务咨询专线:400-780-8018

        (仅限服务咨询,其他事宜请拨打川沙总部电话)

        川沙总部电话: +86 (21) 5859-1500

        海外:

        +1(781)535-1428(U.S.)

        0044 7790 816 954 (Europe)

        Email:marketing@medicilon.com

      在线留言×
      点击切换

      搜索结果包含 tumor 的内容

      Jul 06,2023
      表观遗传修饰,如DNA甲基化,在遗传信息的表达中发挥着重要作用。DNA甲基转移酶维持DNA甲基化,是肿瘤化疗的一个有吸引力的靶点
      Epigenetic modification, like DNA methylation, plays a major role in the expression of genetic information. The DNA methyltransferases (DNMTs), maintain DNA methylation, is an attractive target for tu
      查看更多
      表观遗传修饰,如DNA甲基化,在遗传信息的表达中发挥着重要作用。DNA甲基转移酶维持DNA甲基化,是肿瘤化疗的一个有吸引力的靶点
      Jul 06,2023
      Columbin具有多种药理活性,包括体内抗炎和抗肿瘤活性,此实验中动物研究通过J9九游会老哥俱乐部进行
      Columbin is an important component isolated from Radix Tinosporae. Columbin possesses many pharmacological activities, including anti-inflammation, and antitumor activity in vivo. The purpose of the p
      查看更多
      Columbin具有多种药理活性,包括体内抗炎和抗肿瘤活性,此实验中动物研究通过J9九游会老哥俱乐部进行
      Jul 06,2023
      PTX-HSN是一种高效纳米系统,具有较高耐受剂量,可将PTX递送至卵巢癌并增强主动肿瘤靶向性。此研究中所有体内实验均通过J9九游会老哥俱乐部进行
      Paclitaxel-loaded hyaluronan solid nanoemulsions (PTX-HSNs) were successfully fabricated for the delivery of PTX to improve ovarian cancer treatment via active tumor targeting. The in vivo #toxicity,
      查看更多
      PTX-HSN是一种高效纳米系统,具有较高耐受剂量,可将PTX递送至卵巢癌并增强主动肿瘤靶向性。此研究中所有体内实验均通过J9九游会老哥俱乐部进行
      Jul 06,2023
      AD80是一种多激酶抑制剂,在多种肝细胞癌临床前动物模型中具有抗肿瘤活性,AD80在血浆中的含量通过J9九游会老哥俱乐部进行LC-MS/MS测定
      Liver cancer is the fourth greatest cause of cancer related mortality. AD80 is a multi-kinase inhibitor with anti-tumoral activity across a variety of hepatocellular carcinoma (HCC) preclinical models
      查看更多
      AD80是一种多激酶抑制剂,在多种肝细胞癌临床前动物模型中具有抗肿瘤活性,AD80在血浆中的含量通过J9九游会老哥俱乐部进行LC-MS/MS测定
      Jul 06,2023
      免疫检查点阻断疗法改变了癌症治疗的范式,此研究中通过J9九游会老哥俱乐部在23 个同源肿瘤模型中进行了抗PD-1抗体的体内研究
      Immune checkpoint blockade therapies have changed the paradigm of cancer therapies. Reseachers performed in vivo screening for anti-PD-1 therapy across 23 syngeneic tumor models and found th
      查看更多
      免疫检查点阻断疗法改变了癌症治疗的范式,此研究中通过J9九游会老哥俱乐部在23 个同源肿瘤模型中进行了抗PD-1抗体的体内研究
      Jul 05,2023
      合成具有体内抗肿瘤活性的强效PD-L1抑制剂,并进行生物学评价和机制研究。PK研究通过J9九游会老哥俱乐部进行
      PD-1 and PD-L1 have been very successful for the treatment of various tumors, including NSCLC, urothelial cancer, melanoma, head and neck squamous cell cancer, and lymphoma. Researchers identified com
      查看更多
      合成具有体内抗肿瘤活性的强效PD-L1抑制剂,并进行生物学评价和机制研究。PK研究通过J9九游会老哥俱乐部进行
      Jul 05,2023
      研究人员开发了一种高特异性的CDC7抑制剂TAK-931作为临床肿瘤治疗剂,抗肿瘤药效研究通过J9九游会老哥俱乐部进行
      Cell division cycle 7 (CDC7) plays important roles in DNA replication. Researchers developed a highly specific CDC7 inhibitor, TAK-931, as a clinical cancer therapeutic agent. The antitumor efficacy s
      查看更多
      研究人员开发了一种高特异性的CDC7抑制剂TAK-931作为临床肿瘤治疗剂,抗肿瘤药效研究通过J9九游会老哥俱乐部进行
      Jun 28,2023
      TAK-243是一种有效的泛素激活酶小分子抑制剂,具有体内抗肿瘤功效,通过J9九游会老哥俱乐部使用HCC70模型进行
      TAK-243 is a potent, mechanism-based small-molecule inhibitor of the ubiquitin activating enzyme (UAE), the primary mammalian E1 enzyme that regulates the ubiquitin conjugation cascade. TAK-243 has UAE-specific antitumor efficacy in vivo. Medicilon perfor
      查看更多
      TAK-243是一种有效的泛素激活酶小分子抑制剂,具有体内抗肿瘤功效,通过J9九游会老哥俱乐部使用HCC70模型进行
      Jun 28,2023
      CAR-T疗法主要针对白血病与恶性淋巴瘤,本研究中构建沉默PD-1的shRNA载体质粒,测序后质粒的鉴定通过J9九游会老哥俱乐部进行
      Chimeric antigen receptor T cells (CAR-T) immunotherapy has shown promising clinical results in the treatment of leukemia and lymphoma, but the effectiveness is limited for solid tumors. The shRNA vector plasmid that silences PD-1 and preparation of CAR i
      查看更多
      CAR-T疗法主要针对白血病与恶性淋巴瘤,本研究中构建沉默PD-1的shRNA载体质粒,测序后质粒的鉴定通过J9九游会老哥俱乐部进行
      ×
      搜索验证
      点击切换